These 5 NYC Tech Companies Raised the Most Funding in July

Learn how the companies who raised last month’s largest rounds are investing their new capital.

Written by Cassidy Ritter
Published on Aug. 10, 2022
These 5 NYC Tech Companies Raised the Most Funding in July
NYC skyline
Photo: Shutterstock

NYC’s five largest funding rounds in July totaled a collective $586 million. Funds went to tech companies in a variety of industries ranging from construction and travel to healthtech. Read on to learn how these companies plan to use their latest investments and which ones are hiring. 

 

#5. $38 million, July 12

Assembly OSM, founded in 2019, is a modular construction company that uses tech to speed up design, manufacturing and on-site installation. The company is doing viability work in several cities, including New York, Los Angeles and San Francisco. The Series A round led by Fifth Wall’s climate technology fund brings Assembly’s total funding raised to date to $62 million.

 

#4. $50 million, July 11

The clinical-stage biotech company is developing cancer drugs. Having recently raised a Series D round, Inspirna will use its fresh capital for the clinical development of two of its leading drug candidates focused on colon, lung and endometrial cancers. 

 

#3. $75 million, July 26

The $75 million Series B will go toward growing Spotnana’s current 200-person team. Spotnana’s platform is used by corporations and offers personalized travel bookings for employees. It also claims to reduce travel costs. 

 

#2. $200 million, July 13

Founded in 2009, Pico is a technology service provider offering financial services like trading cloud infrastructure, software and analytic solutions and connectivity. The company has 55 data centers across the Americas, Asia and Europe. The $200 million strategic investment from Golden Gate Capital will be used for M&A opportunities.

 

#1. $223 million, July 25

Using machine learning, Cleerly’s technology can measure plaque build-up in the heart’s arteries. This information is then used to help diagnose heart disease and assist physicians in determining the next steps for care. Cleerly announced on July 25 that it had raised $192 million, but the company announced three days later that the funding amount had grown to $223 million. The Series C round comes one year after its $43 million Series B.

Editor’s note: This article was updated on Aug. 11 to reflect Cleerly’s updated Series C round. Cleerly initially announced a $192 million Series C round on July 25, but after receiving additional funding, the company updated the figure on July 28 to $223 million.

Hiring Now
Peloton
Digital Media • Fitness • Hardware • Mobile • Software